LifeVantage to Announce Fiscal First Quarter 2013 Results on November 8, 2012

company logo

SALT LAKE CITY, Nov. 1, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, including its patented dietary supplement Protandim®, the Nrf2 Synergizer®, announced today it will release financial results for its first fiscal quarter ended September 30, 2012, after the market closes on Thursday, November 8, 2012. The Company will hold an investor conference call at 2:30 p.m. Mountain Standard Time (4:30 p.m. Eastern Standard Time).

Investors interested in participating in the live call can dial (800) 378-1475 from the U.S. International callers can dial (719) 325-2297. A telephone replay will be available approximately two hours after the call concludes and will be available through Saturday, November 10, 2012, by dialing (877) 870-5176 from the U.S., or (858) 384-5517 from international locations, and entering confirmation code 1384523.

There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at The webcast will be archived for 30 days.

To receive email alerts regarding LifeVantage's upcoming investor events, stock information, SEC filings, or Company issued press releases, please visit the Company's investor relations page and sign up for Email Subscription Alerts:

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and is headquartered in Salt Lake City, UT.

The LifeVantage Corporation logo is available at

CONTACT: Investor Relations Contact: Cindy England (801) 432-9036 Director of Investor Relations -or- John Mills (310) 954-1105 Senior Managing Director, ICR, LLC

Source:LifeVantage Corporation